rs143719747
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_015346.4(ZFYVE26):c.3950C>T(p.Thr1317Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,612,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T1317T) has been classified as Likely benign.
Frequency
Consequence
NM_015346.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 15Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Myriad Women’s Health, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ZFYVE26 | NM_015346.4 | c.3950C>T | p.Thr1317Met | missense_variant | Exon 21 of 42 | ENST00000347230.9 | NP_056161.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZFYVE26 | ENST00000347230.9 | c.3950C>T | p.Thr1317Met | missense_variant | Exon 21 of 42 | 1 | NM_015346.4 | ENSP00000251119.5 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152234Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000156 AC: 39AN: 250482 AF XY: 0.000140 show subpopulations
GnomAD4 exome AF: 0.0000815 AC: 119AN: 1460388Hom.: 0 Cov.: 34 AF XY: 0.0000799 AC XY: 58AN XY: 726270 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000308 AC: 47AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74508 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Spastic paraplegia Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1317 of the ZFYVE26 protein (p.Thr1317Met). This variant is present in population databases (rs143719747, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with ZFYVE26-related conditions. ClinVar contains an entry for this variant (Variation ID: 448890). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.3950C>T (p.T1317M) alteration is located in exon 21 (coding exon 20) of the ZFYVE26 gene. This alteration results from a C to T substitution at nucleotide position 3950, causing the threonine (T) at amino acid position 1317 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at